Health Care · Services-Medical Laboratories · Nasdaq · CIK 2019410 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $16.09Day +3.21%Mkt cap $4.5B1Y −45.5%Off 52W high −62.1%Vol (1Y) 60.6%
Daily closing price, split-adjusted to the current basis; 1.1y shown of 1,851 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.2% of sh out |
| Days to cover3.4d |
| 13F net flow (QoQ)+1.57% |
| Top-10 13F concentration68.3% |
| Next report (est.)2026-10-24 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$907.3M |
| Earnings (TTM)$34.0M |
| Net margin−8.4% |
| Debt / equity0.66× |
| Total debt / EBITDA5.60× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−40.4% |
| 1Y−45.5% |
| 3Y−42.5% |
| 5Y−71.0% |
| 10Y+100.0% |
| Since incept. (ann.)+2.2% |
Total return through 2026-07-30 · series begins 2015-08-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)60.6% |
| Ann. volatility (3Y)60.7% |
| Sharpe (1Y)−0.61 |
| Sharpe (3Y)−0.54 |
| Max drawdown (1Y)−63.0% |
| Max drawdown (3Y)−63.0% |
| Beta (3Y vs SPY)0.43 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 30.8M | $550M | 10.89% | +116.5% |
| J. H. Whitney Equity Partners VI, LLC | 18.3M | $326M | 6.46% | −9.9% |
| Sixth Street Partners Management Company, L.P. | 14.4M | $257M | 5.09% | −25.8% |
| COATUE MANAGEMENT LLC | 9.8M | $176M | 3.48% | +0.0% |
| BRAIDWELL LP | 8.0M | $143M | 2.83% | +2.5% |
| PointState Capital LP | 7.4M | $132M | 2.60% | +9.6% |
| T. Rowe Price Investment Management, Inc. | 5.6M | $100M | 1.98% | −57.2% |
| BlackRock, Inc. | 4.9M | $87M | 1.72% | +104.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $0.00 | — | $216.2M | +78.8% |
| 2025-12-31 | 2026-02-26 | — | — | $292.9M | — |
| 2025-09-30 | 2025-11-05 | $0.08 | — | $216.8M | +113.4% |
| 2025-06-30 | 2025-08-12 | −$7.97 | — | $181.4M | +81.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-24 is ESTIMATED from filing cadence (median gap 85d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
